- CARLSMED continues growth with merger, developing industry’s first complete end-to-end personalized surgical workflow platform for spine deformity intervention
- The integrated bioengineering and biomedical platform is being developed to provide better patient outcomes – decreasing trial and error device fitting during surgery, post-op patient complications, and overall surgical cost
SAN DIEGO–(BUSINESS WIRE)–#DisruptiveTechnology–CARLSMED, Inc., a San Diego-based medical technology company, today announced that it has completed a merger with Seattle-based spine imaging system company Precisive Surgical to offer the industry’s first personalized surgical workflow platform. The terms of the merger are not disclosed. The system will enable earlier surgical intervention delivering personalized implant devices to patients with complex, multi-level spinal deviation of alignment. The expected results include better patient outcomes and quality of life, reduction in the use of opioids for pain management, as well as decreased overall surgical costs to the patient, surgeon and hospital/surgery center.
“Today’s imaging for severe spinal deformities is primarily used for diagnostic purposes only,” said Co-Founder and CEO of CARLSMED, Inc. Mike Cordonnier. “The proprietary platform we are developing enables surgeons to use this information directly for surgical intervention. Our platform changes the way traditional radiographic imaging studies are taken. This enables creation of devices and surgical plans in a build-on-demand business model. This technology leap addresses a giant opportunity to use meaningful data for improved patient care.”
“In surgery, we have access to enormous amounts of imaging data preoperatively or intraoperatively that is not currently being harnessed to its fullest extent to improve patient outcomes,” said Co-Founder of Precisive Surgical, spine surgeon and Chief Medical Officer of CARLSMED, Dr. Justin Esterberg. “The system we’re creating will allow us to truly capture this data for each patient and optimize implant dimensions and trajectories for spinal cages and instrumentation to enhance patient outcomes following surgery.”
In addition to the merger, CARLSMED is pleased to announce that entrepreneur, spine surgeon, and IntuitiveX CEO Dr. Jeffrey Roh has been appointed to the Board of Directors. He is joined on the board by co-founders Mike Cordonnier, Niall Casey and Dr. Justin Esterberg.
The CARLSMED system harnesses clinical intelligence, advanced image recognition, and 3d printing technologies to provide cost effective and personalized surgical solutions for patients with a variety of spine disorders. The system will facilitate traditional, MIS and robotic surgical techniques.
“The combination of MedTech expertise at CARLSMED and Precisive Surgical leverages advanced materials in 3d printing, high definition imaging and Machine Learning with the goal of improving the lives of patients by achieving shorter recovery while reducing the need for revision surgery,” said Rory Moore, EvoNexus CEO and Co-Founder. “CARLSMED is the 30th MedTech startup to be admitted to the prestigious EvoNexus incubator. 27 of the 30 achieved venture funding and four have already been acquired.”
CARLSMED is an active portfolio company of EvoNexus, Southern California’s premier technology incubator. EvoNexus enables motivated entrepreneurs to turn their transformative technologies into fundable, commercially-viable companies. Since 2010, $1.7B in funding and acquisition outcomes have been achieved by EvoNexus startups. A total of 27 EvoNexus startups have been acquired since 2013. EvoNexus is supported by strategic corporate sponsors in technology, life sciences and leading sector service providers. For more information, please visit evonexus.org.
Precisive Surgical is the most recent company to spin-out from IntuitiveX, a leading life science technology incubator. For more information, please visit Intuitive-X.com.